Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Cedars Sinai

C. Ha

Guidelines for Ulcerative Colitis Diagnosis and Management

UChicago Medicine

D. T. Rubin

Top Ten Advances in IBD 2023

Northwestern Medicine Gastroenterology

S. Hanauer

Positioning Therapies in IBD (audio only)

Asher Kornbluth

Use of Concomitant Medications in IBD-Evidence, Outcomes, and Risks

Boston University Chobanian & Avedisian School of Medicine

M. Kappelman

Positioning Medical Therapy in IBD

Washington University in St. Louis

M. Ciorba

Debate: Stride II: Should We Treat to Target or Treat to Symptom Res…

EBMed

B. Abraham, A. Charabaty

How I Use JAK Inhibitors for IBD in My Practice

Scripps Health

E. Loftus

Advanced UC Drugs & Positioning - November 2023, IBD School (Sydney,…

Rubin Lab

D. T. Rubin

Biosimilar Medications in Rheumatology: Update

Keck School of Medicine of USC

J. Cho

Optimizing Current IBD Therapies

University of Colorado Department of Medicine

M. Long

DDW 2023 Updates and Perspectives: Evolution in Medical Treatments f…

DDW 2023 Conference Coverage

S. Hanauer

Panel: Positioning of Therapies in IBD in 2024

Boston University Chobanian & Avedisian School of Medicine

L. Grossberg, M. Kappelman, G. Lichtenstein, M. Hamilton

Goals of Treatment in IBD: Treatment Endpoints and Putting Risks int…

MedStar Georgetown and Northwestern University IBD Masterclass

C. Siegel

Management of Pouchitis and Its Complications

MetroHealth

B. Shen

What’s New with the Old: Anti-TNFs and Anti-Integrins in IBD

Scripps Health

J. Sauk

Small Molecule Drugs in IBD: Which Pill to Choose

Florida Gastroenterologic Society

R. Marchioni Beery

ACAAI 2024 Insights: The Bench to Bedside Pathway to Bring a Biologi…

ACAAI 2024 Insights

T. B. Casale

Update of Anti-TNF Therapy in Crohn's Disease

Columbia University

G. Lichtenstein

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed